1. A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care
- Author
-
Zaman, Tauheed, Bravata, Dawn M, Byers, Amy L, Krebs, Erin E, Leonard, Samuel J, Sandbrink, Friedhelm, Barker, Wylie, and Keyhani, Salomeh
- Subjects
Biomedical and Clinical Sciences ,Biological Psychology ,Clinical Sciences ,Psychology ,Pharmacology and Pharmaceutical Sciences ,Opioid Misuse and Addiction ,Drug Abuse (NIDA only) ,Cannabinoid Research ,Substance Misuse ,Opioids ,7.1 Individual care needs ,Generic health relevance ,Mental health ,Good Health and Well Being ,Humans ,Male ,United States ,Analgesics ,Opioid ,Cannabis ,Veterans ,Cross-Sectional Studies ,Pain ,Hallucinogens ,Primary Health Care ,Opioid therapy ,Opiates ,Public Health and Health Services ,Psychiatry ,Clinical sciences ,Epidemiology ,Clinical and health psychology - Abstract
BackgroundCannabis is marketed as a treatment for pain. There is limited data on the prevalence of cannabis use and its correlates among Veterans prescribed opioids.ObjectiveTo examine the prevalence and correlates of cannabis use among Veterans prescribed opioids.DesignCross-sectional study.ParticipantsVeterans with a urine drug test (UDT) from Primary Care 2014-2018, in 50 states, Washington, D.C., and Puerto Rico. A total of 1,182,779 patients were identified with an opioid prescription within 90 days prior to UDT.Main measuresAnnual prevalence of cannabis positive UDT by state. We used multivariable logistic regression to assess associations of demographic factors, mental health conditions, substance use disorders, and pain diagnoses with cannabis positive UDT.ResultsAnnual prevalence of cannabis positive UDT ranged from 8.5% to 9.7% during the study period, and in 2018 was 18.15% in Washington, D.C. and 10 states with legalized medical and recreational cannabis, 6.1% in Puerto Rico and 25 states with legalized medical cannabis, and 4.5% in non-legal states. Younger age, male sex, being unmarried, and marginal housing were associated with use (p
- Published
- 2023